Tuesday, 19 November 2019

Japan’s PMDA issues GMP Certificate to Lupin’s Unit II Mandideep facility

09 October 2019 | News

The PMDA inspection closed with no critical or major observations

Lupin has announced the receipt of GMP (Good Manufacturing Practice) Certificate from the Pharmaceutical and Medical Devices Agency (PMDA), Japan for its Mandideep API facility (Unit II).

The GMP Certificate was issued following an inspection conducted by PMDA between May 14, 2019 and May 17, 2019.

The PMDA inspection closed with no critical or major observations. The GMP Certificate issued by PMDA for Mandideep facility (Unit II) is valid till September 2024.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account